Metabolites of antiarrhythmic drugs: are they clinically important?
作者信息
Kates R E
出版信息
Ration Drug Ther. 1986 May;20(5):1-5.
PMID:3097754
Abstract
摘要
相似文献
1
Metabolites of antiarrhythmic drugs: are they clinically important?
Ration Drug Ther. 1986 May;20(5):1-5.
2
Clinical pharmacokinetics of antiarrhythmic drugs.
Prog Cardiovasc Dis. 1977 Nov-Dec;20(3):217-42. doi: 10.1016/0033-0620(77)90022-6.
3
Clinical pharmacology of old and new antiarrhythmic drugs.新旧抗心律失常药物的临床药理学
Cardiovasc Clin. 1985;15(3):199-248.
4
[Anti-arrhythmia agents (I): Quinidine, procainamide, disopyramide, encainide, propafenone and flecainide].
Nihon Rinsho. 1985 Nov;43(11):2422-7.
5
Cardiac arrhythmias in the elderly: antiarrhythmic drug treatment.老年人的心律失常：抗心律失常药物治疗
Cardiol Clin. 1986 May;4(2):285-303.
6
Antiarrhythmic agents for chronic ventricular arrhythmias.用于慢性室性心律失常的抗心律失常药物。
Compr Ther. 1987 Apr;13(4):26-35.
7
Series on pharmacology in practice. 2. Antiarrhythmic drug therapy.
Mayo Clin Proc. 1979 Aug;54(8):531-42.
8
Antiarrhythmic drugs.
Can Anaesth Soc J. 1986 May;33(3 Pt 2):S65-7. doi: 10.1007/BF03019159.
9
Metabolites of cardiac antiarrhythmic drugs: their clinical role.心脏抗心律失常药物的代谢产物：它们的临床作用。
Ann N Y Acad Sci. 1984;432:75-89. doi: 10.1111/j.1749-6632.1984.tb14510.x.
10
Effects of congestive heart failure on the pharmacokinetics and pharmacodynamics of antiarrhythmic agents.充血性心力衰竭对抗心律失常药物药代动力学和药效学的影响。
Am J Cardiol. 1986 Jan 31;57(3):25B-33B. doi: 10.1016/0002-9149(86)90995-1.
Zotero 插件